Literature DB >> 19810362

Penicillium morneffei, an emerging AIDS-related pathogen--a RIMS study.

S Bhagyabati Devi1, Th Shanti Devi, Robinson Ningshen, Kh Ranjana Devi, Th Bhimo Singh, Ng Brajachand Singh.   

Abstract

Twenty-seven HIV-infected patients with penicilliosis were included to study the clinical, laboratory and therapeutic features of HIV-infected patients with disseminated Penicillium marneffei infection. Diagnosis was based on microscopy and culture. CD4 counts were assessed by flow cytometry. Males (23 out of 27) predominated while the ages ranged from 20 to 54 years (mean 31.5 years). The most common manifestations were fever, weight loss, anaemia and skin lesions. CD4 counts were low in all the patients. The response to treatment with intravenous amphotericin B followed by itraconazole was excellent. Penicillium marneffei has become an important opportunistic pathogen of HIV infection in Manipur. Penicilliosis should be considered in a susceptible patient with a non-specific febrile illness, a low CD4 count and molluscum contagiosum-like skin lesions. Early diagnosis and treatment improve survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19810362

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  2 in total

1.  Penicillium marneffei-stimulated dendritic cells enhance HIV-1 trans-infection and promote viral infection by activating primary CD4+ T cells.

Authors:  Yan Qin; Yuye Li; Wan Liu; Renrong Tian; Qianqian Guo; Shaoyou Li; Hongbin Li; Daojun Zhang; Yongtang Zheng; Li Wu; Ke Lan; Jianhua Wang
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

2.  First observation in a non-endemic country (Togo) of Penicillium marneffei infection in a human immunodeficiency virus-infected patient: a case report.

Authors:  Akouda Akessiwe Patassi; Bayaki Saka; Dadja Essoya Landoh; Awerou Kotosso; Koudjo Mawu; Wemboo Afiwa Halatoko; Majesté Ihou Wateba; Komi Adjoh; Osseni Tidjani; Dominique Salmon; Palokinam Pitché
Journal:  BMC Res Notes       Date:  2013-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.